de Waard, Ellis A. C. http://orcid.org/0000-0002-1483-3156
Sarodnik, Cindy
Pennings, Alexander
de Jong, Joost J. A.
Savelberg, Hans H. C. M.
van Geel, Tineke A.
van der Kallen, Carla J.
Stehouwer, Coen D. A.
Schram, Miranda T.
Schaper, Nicolaas
Dagnelie, Pieter C.
Geusens, Piet P. M. M.
Koster, Annemarie
van Rietbergen, Bert
van den Bergh, Joop P. W.
Funding for this research was provided by:
European Regional Development Fund via OP-Zuid
the Province of Limburg, the Dutch Ministry of Economic Affairs (31O.041)
Stichting De Weijerhorst
the Pearl String Initiative Diabetes
the Cardiovascular Center
Cardiovascular Research Institute Maastricht
School for Public Health and Primary Care
School for Nutrition, Toxicology and Metabolism
Stichting Annadal
Health Foundation Limburg
Janssen-Cilag B.V.
Novo Nordisk Farma B.V.
Sanofi-Aventis Netherlands B.V.
Article History
Received: 26 January 2018
Accepted: 22 March 2018
First Online: 29 March 2018
Compliance with Ethical Standards
:
: Bert van Rietbergen is consultant for Scanco Medical AG. Piet Geusens received Grants from Abbott, BMS, Amgen, UCB, MSD, Novartis, Pfizer, Roche, and Will Pharma and personal fees from Amgen and UCB outside the submitted work. Ellis AC de Waard, Cindy Sarodnik, Alexander Pennings, Joost JA de Jong, Hans HCM Savelberg, Tineke A van Geel, Carla J van der Kallen, Coen DA Stehouwer, Miranda T Schram, Nicolaas Schaper, Pieter C Dagnelie, Annemarie Koster and Joop PW van den Bergh declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study has been approved by the institutional medical ethical committee (NL31329.068.10) and the Minister of Health, Welfare and Sports of the Netherlands (Permit 131088-105234-PG). All participants gave written informed consent.